149x Filetype PPT File size 0.77 MB Source: www.knowledge.scot.nhs.uk
• A CSI can be helpful to ease pain and inflammation • In most cases it should not be used a first-line treatment • Following CSI patients need to engage in treatment/rehab programme (e.g. stretching/strengthening) • Patients from Primary Care should be managed locally for injection without referral into secondary care (i.e. ortho) unless for other specified reasons (e.g. further investigation or surgical option) • Referral should be based on: – Patients clinical need – Pain level – Functional restriction • Co-morbidities need to be taken into account as CSI may be contra-indicated (further information on referral form) • Err on side of caution – The benefit of a CSI must outweigh the risk to patient How does Corticosteroid reduce inflammation? • Corticosteroid mimics cortisol – Cortisol is a hormone produced in the adrenal glands and has multiple effects throughout the body • Cortisol lowers prostaglandin levels reducing the interaction between T Cells and B Cells which are involved in the immune response • Inflammatory response by tissues is reduced Considerations • Before referring for CSI consider the following: – Is an injection appropriate for this patient? – Is the patient happy to be referred for a CSI? – Has a face to face objective assessment been undertaken? – Do you have a clear MSK diagnosis? • e.g. do not refer Post-viral arthralgia, ‘non- specific painful shoulder’ – Has the patient undertaken appropriate conservative management? – Does the patient agree to aftercare (i.e. initial rest, engagement with rehab)? Indications Upper Limb Lower Limb • ACJ (OA and instability) • Knee OA • GHJ Capsulitis • SAB • Plantar fasciitis • De Quervain’s tenosynovitis – Refer to podiatry ESP for US guidance • CMC OA • Trigger finger/thumb • **Not indicated for GTPS/Achilles or patellar tendinopathy** • **NOT indicated for tennis elbow**
no reviews yet
Please Login to review.